Accelerated epigenetic aging in Down syndrome

Aging Cell

Volumn 14, Issue 3, 2015, Pages 491-495

  Horvath, Steve ^a,b   Garagnani, Paolo ^c,d   Bacalini, Maria Giulia ^c,e   Pirazzini, Chiara ^c   Salvioli, Stefano ^c   Gentilini, Davide ^f   Di Blasio, Anna Maria ^f   Giuliani, Cristina ^c   Tung, Spencer ^a   Vinters, Harry V ^a   Franceschi, Claudio ^c,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CNR   (Italy)

^e Personal Genomics Srl   (Italy)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^g Institute of Neurological Sciences   (Italy)

Author keywords

Biomarker of aging; DNA methylation; Down syndrome; Epigenetics

Indexed keywords

MOLECULAR MARKER; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CHEEK MUCOSA; DNA METHYLATION; DOWN SYNDROME; EPIGENETICS; HUMAN; LEUKOCYTE; META ANALYSIS (TOPIC); PREMATURE AGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELOMERE; TRISOMY 21; ADULT; AGED; AGING; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADULT; AGED; AGING; BIOMARKERS; DNA METHYLATION; DOWN SYNDROME; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; MIDDLE AGED; YOUNG ADULT;

EID: 84927909490     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12325     Document Type: Article

References (23)

1. Costa V, Angelini C, D'Apice L, Mutarelli M, Casamassimi A, Sommese L, Gallo MA, Aprile M, Esposito R, Leone L, Donizetti A, Crispi S, Rienzo M, Sarubbi B, Calabrò R, Picardi M, Salvatore P, Infante T, DeBerardinis P, Napoli Cl, Ciccodicola A. (2011) Massive-Scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS ONE 6, e18493.
2. Cuadrado E, Barrena MJ (1996) Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin. Immunol. Immunopathol. 78, 209-214.
3. Devenny DA, Wegiel J, Schupf N, Jenkins E, Zigman W, Krinsky-McHale SJ, Silverman WP (2005) Dementia of the Alzheimer's type and accelerated aging in Down syndrome. Sci. Aging Knowledge Environ. (14):dn1.
4. Esposito G, Imitola J, Lu J, De Filippis D, Scuderi C, Ganesh VS, Folkerth R, Hecht J, Shin S, Iuvone T, et al. (2008) Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Hum. Mol. Genet. 17, 440-457.
5. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan J-B, Gao Y, et al. (2013) Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359-367.
6. Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol. 14, R115.
7. Horvath S, Zhang Y, Langfelder P, Kahn R, Boks M, van Eijk K, van den Berg L, Ophoff RA (2012) Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 13, R97.
8. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schönfels W, Ahrens M, Heits N, Bell JT, Tsai P-C, Spector TD, et al. (2014) Obesity accelerates epigenetic aging of human liver. Proc. Natl Acad. Sci. USA 111, 15538-15543.
9. Houseman EA, Molitor J, Marsit CJ (2014) Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics 30, 1431-1439.
10. Jenkins EC, Ye L, Gu H, Ni SA, Duncan CJ, Velinov M, Pang D, Krinsky-McHale SJ, Zigman WB, Schupf N, et al. (2008) Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. Neurosci. Lett. 440, 340-343.
11. Jones M, Fejes A, Kobor M (2013a) DNA methylation, genotype and gene expression: who is driving and who is along for the ride? Genome Biol. 14, 126.
12. Jones MJ, Farre P, McEwen LM, Macisaac JL, Watt K, Neumann SM, Emberly E, Cynader MS, Virji-Babul N, Kobor MS (2013b) Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome. BMC Med. Genomics 6, 58.
13. Kerkel K, Schupf N, Hatta K, Pang D, Salas M, Kratz A, Minden M, Murty V, Zigman WB, Mayeux RP, et al. (2010) Altered DNA Methylation in Leukocytes with Trisomy 21. PLoS Genet. 6, e1001212.
14. Kimura M, Cao X, Skurnick J, Cody M, Soteropoulos P, Aviv A (2005) Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. Free Radic. Biol. Med. 39, 374-380.
15. Kusters MA, Verstegen RH, de Vries E (2011) Down syndrome: is it really characterized by precocious immunosenescence? Aging Dis. 2, 538-545.
16. Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, Chevalier C, Thurman R, Sandstrom RS, Hibaoui Y, et al. (2014) Domains of genome-wide gene expression dysregulation in Down's syndrome. Nature 508, 345-350.
17. Lott IT, Head E (2005) Alzheimer disease and Down syndrome: factors in pathogenesis. Neurobiol. Aging 26, 383-389.
18. Moran J (2013) Aging and Down Syndrome. ndss: A Health & Well-Being Guidebook.
19. Patterson D, Cabelof DC (2012) Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging. Mech. Ageing Dev. 133, 133-137.
20. Teipel S, Hampel H (2006) Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease. Behav. Genet. 36, 405-415.
21. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP, et al. (2010) Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 20, 440-446.
22. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52, 661-667.
23. Zigman WB (2013) Atypical aging in Down syndrome. Dev. Disabil. Res. Rev. 18, 51-67.